Annual EBIT
-$223.12 M
-$57.44 M-34.67%
31 December 2023
Summary:
Verve Therapeutics annual earnings before interest & taxes is currently -$223.12 million, with the most recent change of -$57.44 million (-34.67%) on 31 December 2023. During the last 3 years, it has fallen by -$182.50 million (-449.20%). VERV annual EBIT is now -1535.57% below its all-time high of -$13.54 million.VERV EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$56.91 M
+$1.93 M+3.28%
30 September 2024
Summary:
Verve Therapeutics quarterly earnings before interest & taxes is currently -$56.91 million, with the most recent change of +$1.93 million (+3.28%) on 30 September 2024. Over the past year, it has dropped by -$4.58 million (-8.74%). VERV quarterly EBIT is now -751.18% below its all-time high of -$6.69 million, reached on 30 June 2020.VERV Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$226.54 M
-$4.58 M-2.06%
30 September 2024
Summary:
Verve Therapeutics TTM earnings before interest & taxes is currently -$226.54 million, with the most recent change of -$4.58 million (-2.06%) on 30 September 2024. Over the past year, it has dropped by -$9.65 million (-4.45%). VERV TTM EBIT is now -2974.24% below its all-time high of -$7.37 million, reached on 31 March 2020.VERV TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VERV EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.7% | -8.7% | -4.5% |
| 3 y3 years | -449.2% | -142.2% | -214.1% |
| 5 y5 years | - | - | - |
VERV EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -449.2% | at low | -142.2% | +3.3% | -214.1% | at low |
| 5 y | 5 years | -1535.6% | at low | -751.2% | +3.3% | -2974.2% | at low |
| alltime | all time | -1535.6% | at low | -751.2% | +3.3% | -2974.2% | at low |
Verve Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$56.91 M(-3.3%) | -$226.54 M(+2.1%) |
| June 2024 | - | -$58.84 M(+3.5%) | -$221.97 M(+0.1%) |
| Mar 2024 | - | -$56.84 M(+5.4%) | -$221.71 M(-0.6%) |
| Dec 2023 | -$223.12 M(+34.7%) | -$53.95 M(+3.1%) | -$223.12 M(+2.9%) |
| Sept 2023 | - | -$52.33 M(-10.7%) | -$216.89 M(+4.1%) |
| June 2023 | - | -$58.58 M(+0.6%) | -$208.41 M(+8.5%) |
| Mar 2023 | - | -$58.26 M(+22.1%) | -$192.02 M(+15.9%) |
| Dec 2022 | -$165.69 M | -$47.71 M(+8.8%) | -$165.69 M(+10.1%) |
| Sept 2022 | - | -$43.86 M(+4.0%) | -$150.52 M(+15.6%) |
| June 2022 | - | -$42.19 M(+32.2%) | -$130.16 M(+24.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$31.93 M(-1.9%) | -$104.93 M(+20.5%) |
| Dec 2021 | -$87.07 M(+114.3%) | -$32.54 M(+38.5%) | -$87.07 M(+20.7%) |
| Sept 2021 | - | -$23.50 M(+38.5%) | -$72.13 M(+25.2%) |
| June 2021 | - | -$16.96 M(+20.6%) | -$57.60 M(+21.7%) |
| Mar 2021 | - | -$14.06 M(-20.1%) | -$47.32 M(+16.5%) |
| Dec 2020 | -$40.63 M(+197.8%) | - | - |
| Dec 2020 | - | -$17.60 M(+96.2%) | -$40.63 M(+76.4%) |
| Sept 2020 | - | -$8.97 M(+34.2%) | -$23.03 M(+63.8%) |
| June 2020 | - | -$6.69 M(-9.3%) | -$14.05 M(+90.7%) |
| Mar 2020 | - | -$7.37 M | -$7.37 M |
| Dec 2019 | -$13.64 M | - | - |
FAQ
- What is Verve Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Verve Therapeutics?
- What is Verve Therapeutics annual EBIT year-on-year change?
- What is Verve Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Verve Therapeutics?
- What is Verve Therapeutics quarterly EBIT year-on-year change?
- What is Verve Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Verve Therapeutics?
- What is Verve Therapeutics TTM EBIT year-on-year change?
What is Verve Therapeutics annual earnings before interest & taxes?
The current annual EBIT of VERV is -$223.12 M
What is the all time high annual EBIT for Verve Therapeutics?
Verve Therapeutics all-time high annual earnings before interest & taxes is -$13.54 M
What is Verve Therapeutics annual EBIT year-on-year change?
Over the past year, VERV annual earnings before interest & taxes has changed by -$57.44 M (-34.67%)
What is Verve Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of VERV is -$56.91 M
What is the all time high quarterly EBIT for Verve Therapeutics?
Verve Therapeutics all-time high quarterly earnings before interest & taxes is -$6.69 M
What is Verve Therapeutics quarterly EBIT year-on-year change?
Over the past year, VERV quarterly earnings before interest & taxes has changed by -$4.58 M (-8.74%)
What is Verve Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of VERV is -$226.54 M
What is the all time high TTM EBIT for Verve Therapeutics?
Verve Therapeutics all-time high TTM earnings before interest & taxes is -$7.37 M
What is Verve Therapeutics TTM EBIT year-on-year change?
Over the past year, VERV TTM earnings before interest & taxes has changed by -$9.65 M (-4.45%)